CLINICAL_TRIALS
trial_result
· 2020-01-03
Clinical Trial Update: Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 [Phase 2]
Summary
Phase 2 trial update on pharmacodynamics, safety, and pharmacokinetics of BMS-663068 (HIV attachment inhibitor) in HIV-1.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-01-03